2. UroToday Home
  3. Video Lectures

SNMMI Curriculum Videos

Appropriate Use Criteria for PSMA PET Imaging - Hossein Jadvar
March 10, 2022
Details
Imaging Prostate Cancer with F18 Fluciclovine PET - Neha Maithel & Isis Gayed
January 28, 2022
Details
PSMA-targeted PET Imaging of Prostate Cancer - A Primer for Urologists - Michael Gorin
November 8, 2021
Details
Symposium Discussion on PSMA-Targeted PET Imaging and Interpretation - What Urologists Need to Know
November 8, 2021
Details
PSMA-Targeted PET Imaging Metastatic Disease, Response Assessment, Future Directions, and Read Paradigms - Steven Rowe
November 5, 2021
Details
Radium-223 Treatment for Metastatic Prostate Cancer - Ila Sethi
August 17, 2021
Details
Imaging With Fluciclovine for Prostate Cancer - Bital Savir-Baruch
March 17, 2021
Details
PSMA Theranostics in Prostate Cancer SNMMI - Richard Baum
December 14, 2020
Details
Discussion from Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium
November 21, 2020
Details
PSMA-Based Diagnostic and Theranostic Strategies in Metastatic Prostate Cancer - Rahul Aggarwal
November 21, 2020
Details
Integrating PSMA-based Fluorescence Molecular Imaging During Robotic Prostatectomy - Hao Nguyen
November 21, 2020
Details
Introduction to PET PSMA Gallium-68 PSMA-11 for Diagnostic Imaging of Prostate Cancer - Tom Hope
November 21, 2020
Details
Management of Oligometastatic Prostate Cancer: From Imaging to Therapy - Felix Feng
November 21, 2020
Details
Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium - Rob Flavell
November 3, 2020
Details
Modulation of PSMA Expression by Androgen Deprivation Therapy (ADT) - Louise Emmett
March 10, 2020
Details
Bone Targeted Theranostics with 18F-NaF/ 223Ra Cl2 in Prostate Cancer - Hossein Jadvar
March 10, 2020
Details
Non-PSMA Based Theranostics in Prostate Cancer - Andrei Iagaru
March 7, 2020
Details
Radiotherapy Planning in Prostate Cancer Patients - Matteo Sepulcri and Laura Evangelista
March 1, 2020
Details
Reproducibility and Repeatability of Quantitative FDHT Uptake Metrics in CRPC - Andrew Scott
February 26, 2020
Details
Early Initiation of Lu177 PSMA Radioligand Therapy Prolongs Survival in Metastatic PCa - Harshad Kulkarni
January 8, 2020
Details
Initial Experience with Actinium- 225 PSMA in Advanced Prostate Cancer - Machaba Michael Sathekge
December 29, 2019
Details
Prognostic Value of Baseline Imaging Parameters Prior to LuPSMA Therapy - Justin Ferdindandus
December 4, 2019
Details
Radium 223 Dichloride Use in Patients with Castrate Resistant Prostate Cancer - Hossein Jadvar
October 3, 2019
Details
SNMMI Osseous Scintigraphy - Ephraim E. Parent
August 14, 2019
Details
Case-based Approaches: PSMA and Personalized Prostate Cancer Care - Frankis Almaguel
August 13, 2019
Details
Bombesin - A New Frontier for Prostate Cancer Imaging - Andrei Iagaru
July 19, 2019
Details
PSMA Theranostics and Personalized Prostate Cancer Care- Frankis Almaguel
July 16, 2019
Details
PET C-11 Choline Imaging in Prostate Cancer Patients with Biochemical Recurrence- Ajit H. Goenka
May 19, 2019
Details
18F-fluciclovine PET/CT in Patients with Suspected Recurrent Prostate Cancer - Bital Savir-Baruch
April 23, 2019
Details
Prostate Cancer Diagnosis and Treatment: Incorporating New PET imaging and Theranostic Approaches - Robert Flavell
May 14, 2019
Details
email news signup